BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16987071)

  • 1. Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.
    Ireland DD; Reiss CS
    Viral Immunol; 2006; 19(3):536-45. PubMed ID: 16987071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice.
    Christian AY; Barna M; Bi Z; Reiss CS
    Viral Immunol; 1996; 9(3):195-205. PubMed ID: 8890478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system.
    Plakhov IV; Arlund EE; Aoki C; Reiss CS
    Virology; 1995 May; 209(1):257-62. PubMed ID: 7747478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb.
    Komatsu T; Reiss CS
    J Immunol; 1997 Oct; 159(7):3444-52. PubMed ID: 9317143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin-18 in vesicular stomatitis virus infection of the CNS.
    Hodges JL; Ireland DD; Reiss CS
    Viral Immunol; 2001; 14(2):181-91. PubMed ID: 11398813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus.
    Iannacone M; Moseman EA; Tonti E; Bosurgi L; Junt T; Henrickson SE; Whelan SP; Guidotti LG; von Andrian UH
    Nature; 2010 Jun; 465(7301):1079-83. PubMed ID: 20577213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes.
    Bussfeld D; Nain M; Hofmann P; Gemsa D; Sprenger H
    J Interferon Cytokine Res; 2000 Jul; 20(7):615-21. PubMed ID: 10926203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
    Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
    J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.
    Maloy KJ; Burkhart C; Junt TM; Odermatt B; Oxenius A; Piali L; Zinkernagel RM; Hengartner H
    J Exp Med; 2000 Jun; 191(12):2159-70. PubMed ID: 10859340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance?
    Ciavarra RP; Stephens A; Nagy S; Sekellick M; Steel C
    J Immunol; 2006 Jul; 177(1):492-500. PubMed ID: 16785546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system.
    Bi Z; Quandt P; Komatsu T; Barna M; Reiss CS
    J Immunol; 1995 Dec; 155(12):5684-9. PubMed ID: 7499854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.
    Bi Z; Barna M; Komatsu T; Reiss CS
    J Virol; 1995 Oct; 69(10):6466-72. PubMed ID: 7545248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.
    Ahmed M; Marino TR; Puckett S; Kock ND; Lyles DS
    J Virol; 2008 Sep; 82(18):9273-7. PubMed ID: 18614644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.
    Huneycutt BS; Bi Z; Aoki CJ; Reiss CS
    J Virol; 1993 Nov; 67(11):6698-706. PubMed ID: 8105106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin (IL)-12 receptor beta1 or IL-12 receptor beta 2 deficiency in mice indicates that IL-12 and IL-23 are not essential for host recovery from viral encephalitis.
    Ireland DD; Palian BM; Reiss CS
    Viral Immunol; 2005; 18(2):397-402. PubMed ID: 16035952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-gamma or IL-4.
    Andersen C; Jensen T; Nansen A; Marker O; Thomsen AR
    Int Immunol; 1999 Dec; 11(12):2035-42. PubMed ID: 10590269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent antigen presentation after acute vesicular stomatitis virus infection.
    Turner DL; Cauley LS; Khanna KM; Lefrançois L
    J Virol; 2007 Feb; 81(4):2039-46. PubMed ID: 17151119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon.
    Ciavarra RP; Taylor L; Greene AR; Yousefieh N; Horeth D; van Rooijen N; Steel C; Gregory B; Birkenbach M; Sekellick M
    Virology; 2005 Nov; 342(2):177-89. PubMed ID: 16143360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system.
    Steel CD; Hahto SM; Ciavarra RP
    Virology; 2009 Apr; 387(1):117-26. PubMed ID: 19264338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.